Expanse UG (haftungsbeschränkt) & Co. KKG – Trademark Portfolio
Entity Type: 99
Expanse UG (haftungsbeschränkt) & Co. KKG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CC COLCUR. The owner is based in M�nchen.
Bavariastr. 15
M�nchen 80336 , DE
Showing of trademarks Trademarks
Trademark Classifications
Expanse UG (haftungsbeschränkt) & Co. KKG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Expanse UG (haftungsbeschränkt) & Co. KKG have?
Expanse UG (haftungsbeschränkt) & Co. KKG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Expanse UG (haftungsbeschränkt) & Co. KKG file in?
Expanse UG (haftungsbeschränkt) & Co. KKG files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Expanse UG (haftungsbeschränkt) & Co. KKG's most well-known trademarks?
Expanse UG (haftungsbeschränkt) & Co. KKG's registered trademark portfolio includes well-known marks such as CC COLCUR. These are among 1 currently registered trademark in the portfolio.
What is Expanse UG (haftungsbeschränkt) & Co. KKG's trademark registration success rate?
Expanse UG (haftungsbeschränkt) & Co. KKG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.